- Johnson & Johnson has proposed a $5.5 billion settlement to resolve ongoing legal disputes over claims that its talc products caused cancer, a fight that has lasted more than a decade.
- The settlement will only take effect if 95% of the remaining 76,000 claimants agree to it.
- Chris Seeger, a lawyer representing about 2,500 clients with talc claims, indicated that the company could ultimately pay $7 billion or more as part of the settlement.
- As part of the settlement, Johnson & Johnson will pay $3 billion next year, with additional payments not due until 2028.
- The company has previously settled about 95% of lawsuits related to mesothelioma and all state consumer protection claims, stating that this settlement brings finality to a 15-year litigation that they consider meritless.
- Johnson & Johnson's lawyers argue that the claims against the company lack scientific merit.
Johnson & Johnson has proposed a $5.5 billion settlement to resolve ongoing legal disputes regarding claims that its talc products caused cancer. This settlement is contingent upon 95% of the remaining 76,000 claimants agreeing to the terms. The company has been embroiled in talc-related lawsuits for over a decade, with its lawyers asserting that the claims lack scientific merit.16
As part of the settlement, Johnson & Johnson will pay $3 billion next year, with additional payments scheduled for 2028. Chris Seeger, a lawyer representing about 2,500 clients with talc claims, indicated that the company could ultimately pay $7 billion or more. The company has previously settled approximately 95% of lawsuits related to mesothelioma, a cancer affecting the tissue surrounding organs, as well as all state consumer protection claims and disputes with talc suppliers. Johnson & Johnson stated that this multi-billion dollar settlement 'brings finality to this meritless 15-year litigation.'345

The proposed settlement aims to resolve a long-standing legal battle that has drawn significant public attention and scrutiny, as many claimants allege that the company's talc products have caused serious health issues, including ovarian cancer. The outcome of this settlement could set a precedent for future cases involving similar claims against the company.
“The settlement aims to resolve claims that Johnson & Johnson's talc products caused ovarian cancer, despite the company's assertion that these claims lack scientific merit. Chris Seeger, a lawyer for 2,500 clients, noted that the total payout could exceed $7 billion, with $3 billion due next year.”


